Large-vessel vasculitis diagnosed between 50 and 60 years: Case-control study based on 183 cases and 183 controls aged over 60 years

Archive ouverte

Delaval, Laure | Daumas, Aurélie | Samson, Maxime | Ebbo, Mikael | de Boysson, Hubert | Liozon, Eric | Dupuy, Henry | Puyade, Mathieu | Blockmans, Daniel | Benhamou, Ygal | Sacre, Karim | Bérezné, Alice | Devilliers, Hervé | Pugnet, Gregory | Maurier, François | Zénone, Thierry | de Moreuil, Claire | Lifermann, François | Arnaud, Laurent | Espitia, Olivier | Deroux, Alban | Grobost, Vincent | Lazaro, Estibaliz | Agard, Christian | Balageas, Alexandre | Bouiller, Kévin | Durel, Cécile-Audrey | Humbert, Sébastien | Rieu, Virginie | Roriz, Mélanie | Souchaud-Debouverie, Odile | Vinzio, Stéphane | Nguyen, Yann | Régent, Alexis | Guillevin, Loïc | Terrier, Benjamin

Edité par CCSD ; Elsevier -

International audience. BackgroundAge at onset of large-vessel vasculitis (LVV) is commonly used to distinguish giant cell arteritis (GCA) and Takayasu arteritis (TA). However, LVV between age 50 and 60 years may be difficult to classify.MethodsWe conducted a retrospective study including LVV aged between 50 and 60 years at onset (LVV50–60, cases) and compared them to LVV aged over 60 years (LVV>60, controls). LVV was defined histologically and/or morphologically. Controls fulfilled ACR 1990 criteria for GCA or presented isolated aortitis.ResultsWe included 183 LVV50–60 and 183 gender-matched LVV>60. LVV50–60 had more frequent peripheral limb manifestations (23 vs. 5%), and less frequent cephalic (73 vs. 90%) and ocular signs (17 vs. 27%) than LVV>60. Compared to LVV>60, CT angiography and PET/CT scan were more frequently abnormal in LVV50–60 (74 vs. 38%, and 90 vs. 72%, respectively), with aorta being more frequently involved (78 vs. 47%). By multivariate analysis, absence of cephalic symptoms, presence of peripheral limb ischemia and aorta involvement, and increased CRP level were significantly associated with LVV50–60 presentation compared to LVV>60. At last follow-up, compared to LVV>60, LVV50–60 received significantly more lines of treatment (2 vs. 1), more frequent biologics (12 vs. 3%), had more surgery (10 vs. 0%), and had higher prednisone dose (8.8 vs. 6.5 mg/d) at last follow-up,ConclusionLVV onset between 50 and 60 years identifies a subset of patients with more frequent aorta and peripheral vascular involvement and more refractory disease compared to patients with LVV onset after 60.

Suggestions

Du même auteur

Temporal Arteritis Revealing Antineutrophil Cytoplasmic Antibody–Associated Vasculitides: A Case–Control Study. Effet d’un traitement par hydroxychloroquine prescrit comme traitement de fond de rhumatismes inflammatoires chroniques ou maladies auto-immunes systémiques sur les tests diagnostiques et l’évolution de l’infection à SARS CoV-2 : étude de 871 patients

Archive ouverte | Delaval, Laure | CCSD

International audience. Objective Temporal arteritis (TA) is a typical manifestation of giant cell arteritis (GCA). Antineutrophil cytoplasmic antibody (ANCA)–associated vasculitides (AAVs) are rarely revealed by TA...

Clinical features and long-term outcomes of patients with systemic polyarteritis nodosa diagnosed since 2005: Data from 196 patients

Archive ouverte | Rohmer, Julien | CCSD

International audience. Introduction Aseptic abscess (AA) syndrome is a rare disease whose pathophysiology is unknown. It is often associated with inflammatory bowel disease and characterised by sterile inflammation...

Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational study

Archive ouverte | Murarasu, Anne | CCSD

International audience. BackgroundProspective data about the risks of thrombotic and severe haemorrhagic complications during pregnancy and post partum are unavailable for women with antiphospholipid syndrome. We ai...

Chargement des enrichissements...